KMC
ICUI icon

Kirr Marbach & Co’s ICU Medical ICUI Stock Holding History

Kirr Marbach & Co’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.65M Buy
45,354
+1,201
+3% +$157K 1.12% 33
2026
Q1 		$5.7M Buy
44,153
+6,863
+18% +$987K 1.04% 31
2025
Q4 		$5.32M Buy
37,290
+1,197
+3% +$160K 1.02% 31
2025
Q3 		$4.33M Sell
36,093
-10
-0% -$1.27K 0.78% 34
2025
Q2 		$4.77M Buy
36,103
+233
+0.6% +$31.6K 0.94% 32
2025
Q1 		$4.98M Buy
35,870
+13,951
+64% +$2.17M 1.16% 31
2024
Q4 		$3.4M Sell
21,919
-1,616
-7% -$273K 0.74% 36
2024
Q3 		$4.29M Sell
23,535
-274
-1% -$40.6K 0.96% 31
2024
Q2 		$2.83M Buy
23,809
+1,269
+6% +$134K 0.68% 35
2024
Q1 		$2.42M Buy
22,540
+876
+4% +$87.1K 0.58% 35
2023
Q4 		$2.16M Sell
21,664
-74
-0.3% -$7.24K 0.57% 37
2023
Q3 		$2.59M Buy
21,738
+139
+0.6% +$20.7K 0.73% 38
2023
Q2 		$3.85M Sell
21,599
-162
-0.7% -$29.7K 1.06% 35
2023
Q1 		$3.59M Buy
21,761
+2,269
+12% +$390K 1.11% 34
2022
Q4 		$3.07M Sell
19,492
-2,319
-11% -$353K 0.96% 38
2022
Q3 		$3.29M Sell
21,811
-30
-0.1% -$4.99K 1.11% 37
2022
Q2 		$3.59M Buy
21,841
+8
+0% +$1.54K 1.13% 38
2022
Q1 		$4.86M Sell
21,833
-95
-0.4% -$21.3K 1.31% 36
2021
Q4 		$5.2M Sell
21,928
-28
-0.1% -$6.54K 1.38% 33
2021
Q3 		$5.12M Sell
21,956
-689
-3% -$144K 1.5% 33
2021
Q2 		$4.66M Buy
22,645
+347
+2% +$71.4K 1.32% 33
2021
Q1 		$4.58M Buy
22,298
+76
+0.3% +$16K 1.33% 34
2020
Q4 		$4.77M Sell
22,222
-317
-1% -$61.5K 1.49% 34
2020
Q3 		$4.12M Sell
22,539
-1,296
-5% -$244K 1.53% 33
2020
Q2 		$4.39M Sell
23,835
-291
-1% -$57.8K 1.57% 31
2020
Q1 		$4.87M Buy
24,126
+840
+4% +$162K 2.08% 24
2019
Q4 		$4.36M Buy
23,286
+734
+3% +$126K 1.01% 39
2019
Q3 		$3.6M Buy
+22,552
New +$4.49M 0.87% 41
2018
Q2 		– Sell
-2,395
Closed -$604K – 85
2018
Q1 		$604K Hold
2,395
– – 0.13% 46
2017
Q4 		$517K Hold
2,395
– – 0.1% 51
2017
Q3 		$445K Buy
2,395
+15
+0.6% +$2.62K 0.1% 53
2017
Q2 		$411K Buy
2,380
+750
+46% +$120K 0.09% 57
2017
Q1 		$249K Sell
1,630
-12,240
-88% -$1.79M 0.06% 62
2016
Q4 		$2.04M Sell
13,870
-7,435
-35% -$1.08M 0.42% 41
2016
Q3 		$2.69M Sell
21,305
-255
-1% -$30.8K 0.54% 42
2016
Q2 		$2.43M Sell
21,560
-1,580
-7% -$164K 0.52% 42
2016
Q1 		$2.41M Buy
23,140
+2,975
+15% +$284K 0.49% 41
2015
Q4 		$2.27M Buy
20,165
+17,960
+815% +$1.98M 0.45% 42
2015
Q3 		$241K Hold
2,205
– – 0.05% 48
2015
Q2 		$211K Buy
+2,205
New +$206K 0.04% 52

Other funds holding ICUI

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
RWP
Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Kirr Marbach & Co's ICUI Position: Q2 2026 in Review

Kirr Marbach & Co increased its ICU Medical (ICUI) stake by 2.7% in Q2 2026, buying an estimated $157K and bringing the position to 45,354 shares worth $6.65M. The position accounts for 1.12% of the portfolio, ranked #33.

Kirr Marbach & Co first reported a position in ICUI in Q2 2015 and has held it in 40 quarters since. 26 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Kirr Marbach & Co held 45,354 shares of ICU Medical worth $6.65M as of Q2 2026.
  • Kirr Marbach & Co bought 1,201 ICU Medical shares in Q2 2026, an estimated $157K.
  • ICU Medical made up 1.12% of Kirr Marbach & Co's portfolio in Q2 2026, its #33 holding.
  • Kirr Marbach & Co first reported a position in ICU Medical in Q2 2015 and has held it in 40 quarters since.
  • 26 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Kirr Marbach & Co's 13F filing for Q2 2026, filed 14 Jul 2026.